The Benefit of Adjuvant Radiotherapy in High-grade Nonmetastatic Retroperitoneal Soft Tissue Sarcoma
Authors:
- 1 March 2018
- journal article
- research article
- Published by Wolters Kluwer Health in American Journal of Clinical Oncology
- Vol. 41 (3) , 274-279
Abstract
Objectives: Controversy persists on the use of adjuvant radiotherapy (RT) in patients with retroperitoneal sarcoma (RPS). High-grade disease is known to be associated with decreased local control and overall survival (OS). Because RT has proven beneficial for local control and OS in patients with high-grade extremity soft tissue sarcoma, we evaluated the efficacy of adjuvant RT in high-grade RPS.Methods: The Surveillance, Epidemiology, and End Results database was used to identify patients with pathology-confirmed RPS from 1973 to 2010. Clinical characteristics and outcomes were analyzed.Results: Of 480 total patients, 144 (30.0%) received postoperative radiation. Patients who received adjuvant RT had improved median OS (36 mo) compared with those who did not (27 mo, hazard ratio [HR]=0.79,P=0.023). On multivariate analysis the use of adjuvant RT (HR=0.80; 95% confidence interval [CI], 0.65-0.98;P=0.029), male sex (HR=1.32; 95% CI, 1.10-1.59;P=0.003), age above 65 years (HR=1.38; 95% CI, 1.15-1.67;P=0.001), and increasing the Surveillance, Epidemiology, and End Results historical stage (HR=1.46; 95% CI, 1.21-1.76;P<0.001) were all prognostic factors for OS.Conclusions: In a large retrospective analysis, postoperative RT improved OS in high-grade RPS patients. As such, adjuvant RT should be strongly considered in all patients with high-grade RPS. The optimal timing of RT relative to surgery requires further study.Keywords
This publication has 50 references indexed in Scilit:
- Locoregional Recurrence After Preoperative Radiation Therapy for Retroperitoneal Sarcoma: Adverse Impact of Multifocal Disease and Potential Implications of Dose EscalationAnnals of Surgical Oncology, 2013
- Comparison of Three-Dimensional (3D) Conformal Proton Radiotherapy (RT), 3D Conformal Photon RT, and Intensity-Modulated RT for Retroperitoneal and Intra-Abdominal SarcomasInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012
- Phase II Study of Neoadjuvant Bevacizumab and Radiotherapy for Resectable Soft Tissue SarcomasInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2011
- Underascertainment of radiotherapy receipt in Surveillance, Epidemiology, and End Results registry dataCancer, 2011
- Radiotherapy and surgery—An indispensable duo in the treatment of retroperitoneal sarcomaCancer, 2011
- Aggressive Surgery in Retroperitoneal Soft Tissue Sarcoma Carried Out at High-Volume Centers is Safe and is Associated With Improved Local ControlAnnals of Surgical Oncology, 2010
- Proton-Beam, Intensity-Modulated, and/or Intraoperative Electron Radiation Therapy Combined with Aggressive Anterior Surgical Resection for Retroperitoneal SarcomasAnnals of Surgical Oncology, 2010
- Predictors of Survival After Resection of Retroperitoneal SarcomaAnnals of Surgery, 2009
- Postoperative nomogram for survival of patients with retroperitoneal sarcoma treated with curative intentAnnals of Oncology, 2009
- Operative Management of Primary Retroperitoneal SarcomasAnnals of Surgery, 2004